在肝-脑轴中探索LRP-1:对阿尔茨海默氏症疾病的影响
1Department of Pharmacology, Govt. College of Pharmacy, Rohru, Shimla, Himachal Pradesh, 171207, India. v4vksharma@gmail.com.
Molecular biology reports
|September 9, 2025
概括
这项研究探讨了阿尔茨海默病 (AD) 中的肝脑轴,突出了肝脏表达的低密度脂蛋白受体相关蛋白-1 (LRP-1) 如何通过清除粉样β和减少神经炎症,为AD提供一种新的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 肝病学 肝病学是一种肝病学.
- 老年学是一门学科.
背景情况:
- 阿尔茨海默病 (AD) 是一种复杂的痴呆症,其特征是认知和运动障碍,目前的治疗只能提供症状缓解.
- 阿尔茨海默病的发病包括粉样β (Aβ) 失调和代谢功能障碍,越来越多的证据涉及肝脏等外围器官.
- 人们越来越认识到肝脏在全身稳定,Aβ清除和AD关键病理特征 (如氧化应激和神经炎症) 的调节中的作用.
研究的目的:
- 为了研究肝脑轴在阿尔茨海默病 (AD) 发病过程中的作用.
- 探索肝脏低密度脂蛋白受体相关蛋白-1 (LRP-1) 在调节AD相关病态中的功能.
- 建议肝脏LRP-1作为阿尔茨海默病的潜在治疗点.
主要方法:
- 关于肝脏参与AD的新兴证据的审查.
- 分析低密度脂蛋白受体相关蛋白-1 (LRP-1) 在肝脏和大脑环境中的作用.
- 检查LRP-1在血脑屏障 (BBB) 和中枢神经系统 (CNS) 的表达和功能.
主要成果:
- 肝脏LRP-1在外周粉样β (Aβ) 清除中起着至关重要的作用.
- 肝脏LRP-1的激活已被证明可以减少AD的关键神经病理过程,包括氧化应激,胰岛素抵抗,病理,神经炎症和亡.
- 在大脑中LRP-1的存在,特别是在血脑屏障 (BBB) 中,强调了它在神经保护中的重要性.
结论:
- 肝脑轴在阿尔茨海默病 (AD) 进展中起着重要作用.
- 肝脏低密度脂蛋白受体相关蛋白-1 (LRP-1) 作为AD病理学的中心调解者.
- 准肝脏LRP-1是一种有前途的新疗法策略,用于对抗阿尔茨海默病.
相关概念视频
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Long-term Depression
3.1K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
3.1K
Long-term Depression
33.2K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.2K
Alzheimer's Disease: Treatment
827
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
827
Neural Regulation
43.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.2K


